Search
Search
Next-Generation Sequencing (NGS) technology has revolutionized the field of Human Leukocyte Antigen (HLA) typing, which is critical for organ transplantation, disease association studies, and immune response research. NGS offers a powerful, precise, and efficient approach for high resolution HLA typing, improving the matching process in transplantation and enhancing our understanding of the genetic foundations of the immune system.
We offer a comprehensive portfolio that meets the diverse needs of the HLA genotyping market and our One Lambda NGS assays are designed for simplicity and flexibility across sequencing platforms.
|
AllType Assays |
|||
Library prep method |
Amplicon (Long Range PCR) | Amplicon |
Amplicon |
Hybrid capture |
Instrument compatibility |
|
|
|
|
Barcode type |
Combinatorial dual index |
Combinatorial dual index |
Combinatorial dual index |
Unique dual index |
| DNA fragmentation method | N/A | Physical shearing | Enzymatic shearing | Enzymatic shearing |
Hands-on time |
1.5 hours |
3.5 hours |
1.5 hours |
2.5 hours |
Turnaround time |
Same day |
3 days |
Next day |
Next day |
Samples per run |
|
|
|
|
Loci |
11 loci: HLA-A, B, C, DRB1, DRB345, DQB1, DQA1, DPB1, and DPA1 | 11 loci: HLA-A, B, C, DRB1, DRB345, DQB1, DQA1, DPB1, and DPA1 | 11 loci: HLA-A, B, C, DRB1, DRB345, DQB1, DQA1, DPB1, and DPA1 | 18 loci: A, B, C, DRB1, DRB345, DQB1, DQA1, DPB1, DPA1, E, F, G, H, J, MICA, MICB |
Resolution |
|
|
|
|
Application |
|
|
|
|
Not all products listed are CE marked in the EU or 510(k)-cleared in the US for in vitro diagnostic use. Availability of product in each country depends on local regulatory marketing authorization status. Not all products are available in all countries. Please consult your local sales representative for details.